Cargando…
Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches
The current global debacle of COVID-19, spelled by SARS-CoV-2 needs no elaboration. With incessant and constantly clambering number of deaths across various nations, the need of the hour is to develop readily deployable, fast, affordable detection assays and kits, yielding precise and consistent res...
Autor principal: | Konwarh, Rocktotpal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511716/ https://www.ncbi.nlm.nih.gov/pubmed/33134311 http://dx.doi.org/10.3389/fmolb.2020.557377 |
Ejemplares similares
-
Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
por: Konwarh, Rocktotpal
Publicado: (2020) -
Félicitations
Publicado: (1971) -
Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid
por: Li, Xiaoping, et al.
Publicado: (2023) -
Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022) -
Fiasco /
por: Lem, Stanisaw, 1921-
Publicado: (1991)